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Background: Alterations towards a permissive stromal microenvironment provide important cues for tumor
growth, invasion, and metastasis. In this study, Fibroblast activation protein (FAP), a serine protease selectively
produced by tumor-associated fibroblasts in over 90% of epithelial tumors, was used as a platform for studying
tumor-stromal interactions.
We tested the hypothesis that FAP enzymatic activity locally modifies stromal ECM (extracellular matrix)
components thus facilitating the formation of a permissive microenvironment promoting tumor invasion in human
pancreatic cancer.
Methods: We generated a tetracycline-inducible FAP overexpressing fibroblastic cell line to synthesize an in vivo-
like 3-dimensional (3D) matrix system which was utilized as a stromal landscape for studying matrix-induced cancer
cell behaviors. A FAP-dependent topographical and compositional alteration of the ECM was characterized by
measuring the relative orientation angles of fibronectin fibers and by Western blot analyses. The role of FAP in the
matrix-induced permissive tumor behavior was assessed in Panc-1 cells in assorted matrices by time-lapse
acquisition assays. Also, FAP
+ matrix-induced regulatory molecules in cancer cells were determined by Western blot
analyses.
Results: We observed that FAP remodels the ECM through modulating protein levels, as well as through
increasing levels of fibronectin and collagen fiber organization. FAP-dependent architectural/compositional
alterations of the ECM promote tumor invasion along characteristic parallel fiber orientations, as demonstrated by
enhanced directionality and velocity of pancreatic cancer cells on FAP
+ matrices. This phenotype can be reversed
by inhibition of FAP enzymatic activity during matrix production resulting in the disorganization of the ECM and
impeded tumor invasion. We also report that the FAP
+ matrix-induced tumor invasion phenotype is b1-integrin/
FAK mediated.
Conclusion: Cancer cell invasiveness can be affected by alterations in the tumor microenvironment. Disruption of
FAP activity and b1-integrins may abrogate the invasive capabilities of pancreatic and other tumors by disrupting
the FAP-directed organization of stromal ECM and blocking b1-integrin dependent cell-matrix interactions. This
provides a novel preclinical rationale for therapeutics aimed at interfering with the architectural organization of
tumor-associated ECM. Better understanding of the stromal influences that fuel progressive tumorigenic behaviors
may allow the effective future use of targeted therapeutics aimed at disrupting specific tumor-stromal interactions.
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Increasing evidence demonstrates the significance of the
tumor microenvironment for tumor initiation and pro-
gression [1-6]. The tumor microenvironment is charac-
terized by a heterogeneous complex of cellular and
acellular components including tumor-associated fibro-
blasts, immune and endothelial cells, soluble cytokines,
chemokines and proteases, as well as a characteristically
remodeled ECM [7]. These components act in a coordi-
nated manner to regulate the growth and differentiation
of adjacent cells, thus alterations in the stromal micro-
environment towards a permissive environment provide
important cues for tumor growth, invasion, and metasta-
sis [7,8]. In fact, the majority of proteases and stromal
factors associated with malignant tumors are secreted by
the host stroma rather than by the tumor cells them-
selves [9-11]. One of the most selective proteins for
tumor stromal fibroblasts is the Fibroblast Activation
Protein (FAP).
FAP is a serine protease that contains both dipeptidyl
peptidase and gelatinase/collagenage activities in vitro
[12]. Because of its specific induction in tumor-asso-
ciated fibroblasts in over 90% of epithelial tumors,
including pancreas and breast among others, FAP was
used as a platform for studying stromal specific effects
on tumor behaviors [13-18]. Previously, we reported
that FAP overexpression by tumor cells results in
increased tumorigenicity and tumor growth [16] and its
enzymatic activity played an important role in the pro-
motion of tumor growth in mouse model [17]. Although
several studies have shown that FAP expression in
human melanoma cell lines or hepatic stellate cells pro-
motes an invasive phenotype through cell adhesion
pathways [13-15], it is not clear how FAP expressing
fibroblast-specific signals prepare a permissive stromal
microenvironment and how modified ECMs influence
cancer cell behavior in vitro.
Studies in several human cancer types describing
alterations in stromal cells and their ECM compositions
suggest that changes in the microenvironment and tis-
sue architecture contribute to tumorigenesis [19]. In
vivo, the mesenchymal ECM is comprised of several
proteins including collagens I, III and fibronectin, which
assemble in an intricate fibrillar network and are
engaged by transmembrane receptors. For example,
integrins transmit biochemical and mechanical stimuli
from the matrix to the cytoskeleton of the cell and back
to the ECM, triggering distinct intracellular signaling
pathways that control proliferation, survival, and migra-
tion [20]. In fact, it has been shown that both desmo-
plastic fibronectin and collagen I fibers often align in
parallel patterns in response to tumorigenesis [21,22],
and these fibers are engaged by integrin heterodimers in
pancreatic and other cancers [6,20], suggesting that cell
behavior can be affected by the underlying stromal sub-
strates via integrin engagement. Thus, alteration of the
stromal ECM composition in cancers may be linked to
cancer progression through tissue remodeling processes
[23]. Here, we show that FAP enzymatic activity locally
modifies stromal ECM components thus facilitating the
formation of a permissive microenvironment promoting
tumor invasion on human pancreatic cancer.
Methods
Cell lines and murine xenograft model
All cell lines used in this study were originally pur-
chased from ATCC or obtained from the Cell Culture
Facility at Fox Chase Cancer Center. Three C.B17/Icr-
scid mice were subcutaneously injected with 2 × 10
6
cells of each pancreatic cell line (Panc-1, Capan-1,
AsPC-1, and HPAF-II). After 5 weeks inoculation,
tumors were harvested for immunohistochemistry
analysis.
Stable transfection of fap in NIH-3T3 fibroblasts
Mouse fap gene was cloned downstream of the Tet-
response promoter in a tetracycline-inducible expression
vector pTRE (a kind gift from Dr. Teresa Ramirez-Mon-
tagut, Memorial Sloan-Kettering Cancer Center, NY).
This construct was co-transfected into NIH-3T3 cells
with rtTA plasmid (pUHD172-1 neo) that encodes the
pTRE promoter-binding transactivator, thus murine
FAP expression was induced by adding Doxycycline
(Dox, 2 μg/ml) into complete DMEM medium contain-
ing 10% Tet system approved Fetal Bovine Serum (Clon-
tech, CA).
Isolation of human pancreatic stellate cells and matched
pancreatic adenocarcinoma-associated fibroblasts
Fresh surgical tissue (decoded) samples from a pancrea-
tic Whipple conducted at the Fox Chase Cancer Center
was delivered with the assistance of the Protocol
Laboratory and the Biosample Repository Facility follow-
ing protocols approved by the Institutional Review
Board. Tissue samples corresponding to pancreatic ade-
nocarcinoma and distant (normal) pancreas were rinsed
in cold PBS containing 100 μg/ml streptomycin and 100
U/ml penicillin. The two types of samples were carefully
minced and incubated overnight with 0.2% collagenase
at 37°C for digestive dissociation. The digested material
was subjected to centrifugation at 1200 rpm for 5 min,
thus precipitating a fibroblast-enriched fraction. This
fraction was filtered through a series of 100 μm followed
by 40 μm cell-strainer (BD Bioscience) before culturing
in DMEM containing 10% FBS, 100 U/ml penicillin, 100
μg/ml streptomycin and 2 mM L-glutamine at 37°C
using a humidified atmosphere and 5% CO2 for a period
of 4 hours before removing the non adherent cells. Cell
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Page 2 of 13homogeneity was confirmed by direct microscopic
observations, while cells were designated as fibroblastic
following confirmation of mesenchymal marker vimen-
tin expression, as well as absence of epithelial marker
cytokeratin 19 expression. In addition, normal fibro-
blasts were characterized as pancreatic stellate cells fol-
lowing confirmation of uptake and storage of vitamin A,
by auto-fluorescence stemming from retinyl acetate
(Sigma) containing droplets [24]. The resultant (PaSCs)
and pancreatic tumor-associated fibroblasts (which were
confirmed to have lost the vitamin A droplets) were
used for self-derived matrix characterization.
Western analysis of FAP induction in fibroblasts
FAP-transfected fibroblasts were harvested at different
time points (0, 1, 2, 4, 6, 8, and 10 days) in the presence
or absence of Dox. Total protein was extracted using
M-Per reagent (Pierce, IL), resolved by 4-12% SDS-
PAGE under reducing conditions (Invitrogen, CA), and
blotted with rabbit monoclonal anti-mouse FAP anti-
body (0.08 μg/ml). Immuno positive bands were labeled
using goat anti-rabbit-HRP (3000×, Amersham
Bioscience, UK) and visualized by ECL reagent (Pierce,
IL). Purified murine recombinant FAP protein (92 kD)
and parental NIH-3T3 cell lysate were used as positive
and negative controls, respectively.
Fibroblast-derived 3D matrix production
All fibroblasts were seeded at a concentration of 7 × 10
5
cells per sample onto 35 mm plates pre-coated with
0.2% gelatin. Confluent fibroblastic cultures were treated
with media supplemented with 50 μg/ml ascorbic acid
(and Dox when necessary) every other day for 8 days to
obtain un-extracted 3D cultures. Alkaline detergent
treatment (0.5% Triton X-100, 20 mM NH4OH in PBS)
for 5 minutes at 37°C gave rise to cell-free in vivo-like
3D matrices [25,26]. For control, FAP-transfected fibro-
blasts were used to make FAP
- matrix in the absence of
Dox. To make FAP+inhibitor matrix, FAP-specific small
molecule inhibitor naphthalenecarboxy-Gly-boroPro
(400 μM, provided by Dr. William Bachovchin, Tufts
University, MA) was added to the media during matrix
production.
Analysis of fibronectin fiber orientation
For indirect immunofluorescent labeling of matrix
fibers, un-extracted 3D cultures were prepared on glass
cover slips as described [21]. Cells were stained with
rabbit anti-mouse fibronectin antibody (25 μg/ml,
Abcam, UK), a donkey anti-rabbit Cy5 conjugated anti-
body (15 μg/ml, Jackson ImmunoResearch, PA) and
DAPI.
From two independent experiments with duplicate
samples, minimum of 5 images per experimental sample
were obtained using a z-stack function of the spinning
disc microscope (PerkinElmer Life Sciences, PA). Each
slice measured 0.5 μm and stacks were reconstituted as
a maximum projection using the MetaMorph software
as described in detail [21]. Fiber distributions corre-
sponding to each experimental setting were determined
by the percentage of fibers that were oriented at 10
0
variation angles from the identified modes.
In-Cell Western analysis of un-extracted 3D cultures
FAP-transfected fibroblasts (1.5 × 10
4 cells/48-well
plate) were cultured in the presence or absence of Dox
during matrix production. Fibroblasts were fixed with
4% paraformaldehyde, permeabilized with 0.1% Triton
X-100 in PBS, and stained with antibodies followed by
manufacturer’s directions (Li-Cor Bioscience, NE). The
antibodies for this assay were tenascin C (50 μg/ml,
Abcam, UK), a-S M A( 5μg / m l ,S i g m a ,M O ) ,c o l l a g e nI
(25 μg/ml, Chemicon International, CA), fibronectin (20
μg / m l ,A b c a m ,U K ) ,b-actin (1000×, Cell Signaling
T e c h n o l o g y ,M A ) ,a n dG A P D H( 2μg/ml, Chemicon
International, CA). Fluorescence-labeled secondary anti-
bodies IRDye 680 and IRDye800CW (Li-Cor Bioscience,
NE) were used to scan by the Odyssey Infrared Imaging
System. The protein levels were normalized by b-actin
or GAPDH.
Western analysis of pancreatic cancer cells cultured
within assorted matrices
Following 2 days culture on matrices, Panc-1 cells were
l y s e di ne x t r a c t i o nb u f f e r( 5 0m MT r i s - H C l ,p H 8 . 8 ,1 %
SDS, 5 mM DTT, 13 mM iodoacetamide, 5 mM EDTA,
150 mM NaCl). Proteins were quantified by western
blot analysis using ECL reagent (Pierce, IL) or Odyssey
infrared imaging system following the manufacturer’s
directions (Li-Cor Bioscience, NE). The antibodies for
this assay were b1-integrin (2500×, BD Transduction
Laboratories, NJ), AKT (500×, BD Transduction Labora-
t o r i e s ,N J ) ,p S
473-AKT (1000×, Cell Signaling Technol-
ogy, MA), FAK (1 μg/ml, Upstate, NY), pY
397-FAK
(1000×, Biosource, CA), and GAPDH (2 μg/ml, Chemi-
con International, CA). Specific activity of AKT and
FAK were calculated as the ratio of the scanned optical
density of phosphorylated protein/total protein. Then
the ratios were normalized by GAPDH.
Motility assay within the assorted 3D matrices
As described in detail [26], tumor cells were re-plated
onto the matrices and incubated overnight. Cell move-
ments (10~15 cells), recording cells migrating both on
and through the matrix, were recorded every 10 minutes
during 12 hours using Nikon TE-2000U inverted micro-
scope equipped with cool snap HQ camera. Individual
cell dynamics were analyzed using the MetaMorph
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distance (D, μm) by calculating the number of μm/pixel.
2) The path trajectory of an individual cell during the
recording period (T, μm). 3) Average velocity as the
motility rate (AV, μm/hr). 4) Directionality calculated by
the D/T ratio, which determines random (D/T = signifi-
cantly smaller than 0.5) versus directional (D/T = close
to 1) migration of individual cells [27-29]. Motility
experiments using the assorted matrices were performed
a minimum of 3 times using different batches of
matrices and following a minimum of 10 individual
cells.
In order to assess the effect on motility by integrin
inhibitors, motility assays were performed in the pre-
sence of functional blocking b1 integrin antibody
mAb13 (50 μg/ml, a kind gift from Dr. K. Yamada at
NIH/NIDCR, Bethesda, MD) or the a5b1-integrin block-
ing peptide ATN-161 (Ac-PHSCN-NH2, 50 μg/ml,
Attenuon, San Diego, CA). These experiments were per-
formed at least 2 times using two alternative batches of
matrices.
Statistic analyses
Data from 3D matrix fiber distribution were analyzed
using “chi-squared test”. The normalized western data
were analyzed using linear regression. For the motility
analysis, the average velocity, net path distance and the
path trajectory were analyzed using Gamma regression,
and the directionality was analyzed using linear
regression.
Immunohistochemistry
Quick snap frozen tumor tissues sections (10 μmt h i c k )
from pancreatic cancer patients and xenografted mouse
tumor tissues were incubated with rat monoclonal anti-
h u m a nF A Pa n t i b o d yD 8( 2 0 × ,ak i n dg i f tf r o mD r .
Wen-Tien Chen, State University of New York, NY) and
rabbit polyclonal anti-mouse FAP antibody (2 μg/ml)
[16], respectively. Biotin-streptavidin detection with
horseradish peroxidase (BioGenex, CA) was applied for
the amplification and visualization of signals following
the manufacturer’s directions. Note that results stem-
ming from this method are depicted in supplemental
Figure 1.
Results
In vivo tumor-dependent stromal FAP upregulation
provides the rationale to study in vitro FAP fibroblastic
over-expression effects
Some reports suggest that FAP expression can occur in
both the stroma and epithelial compartments of cancers
[30-33]. However, the selectivity of FAP for stromal
fibroblasts, but not epithelial tumor cells, has been con-
firmed either by immunohistochemical studies in
pancreas, colorectal and breast cancer patients
[12,34,35], or by RT-PCR of pancreas, lung, and renal
cell xenografts [36]. To confirm the putative significance
of studying FAP-expression effects in stromal matrices,
we first examined FAP expression in the human pan-
creatic cancer patient tissues and mouse xenografts by
immunohistochemistry. We observed that FAP is highly
expressed on the stromal fibroblasts of human pancrea-
tic cancer, while it is undetectable both in the epithelial
cancer cells (Additional file 1, Fig. S1A) and normal tis-
sue (not shown). In xenograft mouse models inoculating
the human pancreatic cancer cell lines (HPAF-II,
Capan-1, AsPC-1, and Panc-1), murine FAP expression
was also found up-regulated specifically at the tumor
stroma (Additional file 1, Fig. S1B). This observation
confirmed the existence of a selectivity of FAP expres-
sion in tumor-associated fibroblasts and prompted us to
believe that perhaps FAP is an attractive protein to
study stromal effects imparted upon tumor behaviors.
Stable FAP expression on naive fibroblasts
In vivo, FAP is highly expressed on pancreatic tumor
stromal fibroblasts, but its expression ex vivo on cul-
tured primary cells is not maintained. To establish stable
FAP-expressing fibroblasts, mouse fap gene was cloned
under the Tet-inducible system. Induction of FAP
expression was achieved as early as 24 hours following
Dox treatment, and its expression was clearly main-
tained for at least 10 days (Figure 1A). Parental NIH-
3T3 cells and FAP
+ fibroblasts cultured in the absence
of Dox showed no detectable FAP induction, allowing
the use of these fibroblasts as negative controls.
FAP expression on fibroblasts during 3D matrix
production induces tumor stromal-like parallel orientation
of fibronectin and collagen I fibers
During the 8 days required to produce a fibroblast-
derived 3D matrix, clear morphological differences on





e l o n g a t e di n t oa ne n h a n c e ds p i n d l e ds h a p e ,a n dt h e y
organized in a parallel pattern (data not shown). Since
tumor-associated ECMs are organized in parallel pat-
terns [21,22,37], we tested whether FAP expression
affects the topography of fibroblasts-derived ECMs by
indirect immunofluorescence using anti-fibronectin
(Figure 1) or anti-collagen I (Additional file 2, Fig. S2)
antibodies on un-extracted matrices containing their
original matrix-synthesizing fibroblasts [21]. Indeed,
FAP
+ fibroblasts produced ECM fibers oriented in par-
allel patterns when compared to FAP
- matrices (Figure
1B). These patterns are reminiscent of previously
observed tumor-associated patterns in vitro [21]. In
addition, the level of organization of the assorted
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Page 4 of 13Figure 1 Matrix fiber organization is increased in FAP
+ matrices. (A) Western analysis showed that FAP was overexpressed in a Tet-inducible
fap-transfected NIH-3T3 fibroblast as early as 24 hours following Dox treatment, and its expression maintained for at least 10 days. Parental NIH-
3T3 cells and FAP
+ fibroblasts in the absence of Dox showed no detectable FAP induction. Recombinant FAP protein (Re-FAP, 92 kD) was used
as positive control. (B) Un-extracted matrices were analyzed for the levels of fiber orientation by indirect immunofluorescence using a fibronectin
antibody (green) and DAPI (blue). FAP
+ fibroblasts produced ECM fibers with enhanced parallel pattern compared to FAP
- and FAP+inhibitor
matrices. The fiber distribution was determined by calculating the % of fibers arranged in parallel for each acquired region (± 10
0 of the mode
angle). The observed % of fibers was 27%, 45%, and 29% for FAP
-, FAP
+, and FAP+inhibitor ECMs, respectively.
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measuring the relative orientation angles of fibers [21].
The average percent of parallel fibers that were
oriented within ±10
0 of the mode angle was deter-
mined using the MetaMorph software. The measured
percentages were 27% and 45% for FAP
- and FAP
+ 3D
ECMs, respectively (p < 0.001) (Figure 1B). Further-
more, inhibition of FAP enzymatic activity by the FAP
inhibitor during the matrix production effectively
reversed the FAP-induced parallel matrix orientation
(29%). Moreover, the observed architectural patterns
were similar to the ones seen in desmoplastic reactions
in human pancreatic cancers and in xenografted
tumors formed in mice using human pancreatic cancer
cells in vivo (see asterisks in Additional file 1, Fig. S1).
Importantly, when assessing the architectural patterns
of collagen I fibers using the FAP series of un-
extracted matrices in vitro, our results showed that,
although the collagen I fibrillogenesis levels during
matrix production (8 days) were not as substantial as
to allow the analysis of the fiber orientation, simple
microscopy observations clearly demonstrated that
FAP
+ fibroblasts indeed affect collagen I fiber organiza-
tion (Additional file 2, Fig. S2). These results suggest
that the FAP enzymatic activity during matrix produc-
tion is important for the topographical organization of
the ECM fibers. Because of this topographical similar-
ity to that of tumor permissive 3D ECMs [25,37], the
FAP
+ 3D matrix system was used to study the mechan-
ism of matrix-supported pancreatic cancer cell
invasion.
Human pancreatic stellate cells- and adenocarcinoma-
derived ECMs resemble FAP null and FAP
+ ECMs,
respectively
It is known that FAP exhibits very restricted expression
in normal adult tissue [38] and that pancreatic stellate
cells are the ‘normal’ fibroblastic cells found in the exo-
crine pancreas. Activated pancreatic stellate cells (i.e.,
myofibroblastic cells) express a-SMA and FAP (among
other markers) and correspond to the cells believed to
be responsible for the fibrosis in chronic pancreatitis
and the desmoplastic reactions in pancreatic adenocarci-
nomas [39]. To compare our observations of the specific
matrix architectures stemming from the FAP matrix ser-
ies to matrices derived from normal pancreas human
stellate cells and activated adenocarcinoma-associated
fibroblasts, we proceeded to isolate these two types of
human pancreatic fibroblastic cells from matched fresh
surgical normal and pancreatic tumor (i.e., adenocarci-
noma) samples (see Materials and Methods). Our results
shown in Figure 2 present the standard bundle pattern
of ECM fiber structures observed in FAP
- matrix. More-
over, human pancreatic adenocarcinoma-associated
fibroblasts produced ECMs oriented in parallel patterns,
which are similar to the patterns formed by FAP
+
Figure 2 Human pancreatic normal stellate cells and adenocarcinoma-derived ECMs resemble FAP
- and FAP
+ ECMs, respectively.
Human normal pancreatic stellate cells and pancreatic tumor-associated fibroblasts were isolated from fresh surgical tissue samples
corresponding to matched (from the same case) normal pancreas (at least 2 cm away from the tumor) and pancreatic adenocarcinoma. Similar
to images shown in Figure 1B, un-extracted human fibroblastic pancreas matrices (anti-fibronectin in green) were subjected to indirect
immunofluorescence while cells’ nuclei were labeled with DAPI (blue). Note how human pancreatic adenocarcinoma-associated fibroblasts
produced ECMs oriented in parallel patterns, which are similar to the patterns formed by FAP
+ matrices while normal pancreatic stellate cells-
derived matrices resemble FAP
- ECMs.
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FAP
+ fibroblast-derived matrices effectively recapitulate
tumor stromal ECMs and that perhaps these matrices
also have the capacity of producing matrices permissive/
inductive of pancreatic tumorigenesis.
Stromal FAP modulates the expression levels of assorted
ECM proteins
The ECM proteins and endogenous desmoplastic pro-
teins (a-SMA) have been known to be up-regulated in
pancreatic stromal reactions (desmoplasia) and play an
active role in tumorigenesis [40]. The levels of ECM
proteins (tenascin C, collagen I and fibronectin) and
cellular a-SMA potentially underlying the matrix dif-
ferences mediated by FAP were measured on the
assorted un-extracted matrices (Figure 3). The expres-
sions of a-SMA, fibronectin, and collagen I were sig-
nificantly up-regulated in FAP
+ matrix compared to
FAP
- matrix (p = 0.009, p = 0.002, p = 0.001, respec-
tively), while tenascin C was significantly down-regu-
lated in FAP
+ matrix (p = 0.001). Thus FAP expression
in fibroblasts during matrix production alters ECMs
composition, as well as its topography (e.g., fibronec-
tin-fiber orientation). Interestingly, compared with
FAP
-, inhibition of FAP enzymatic activity during FAP
+ matrix production enhanced fibronectin and a-SMA
expression (p = 0.04 and p = 0.04, respectively) to
levels comparable to the ones observed in FAP
+ cul-
tures in the absence of the inhibitor. In fact, the P
values for FAP
+ vs. FAP
+inhibitor were 0.32 and 0.61
for fibronectin and a-SMA, respectively. On the other
hand, blocking FAP activity during FAP
+ matrix pro-
duction significantly down-regulated collagen I (p =
0.007), bringing the levels of this ECM protein back to
levels similar to the ones observed in FAP
- matrix.
These results suggest that collagen I production may
be FAP activity dependent (Figure 3).
FAP
+ 3D matrices promote the invasiveness of pancreatic
cancer cells
To determine the effects of the ECM on the invasive
behavior of cancer cells, time-lapse acquisition assays
were performed using pancreatic cancer cell lines that
are known for their distinct invasive and metastatic
potentials in vivo [41]. The more metastatic cell lines
(Capan-1, Panc-1) and the less aggressive cells (AsPC-1,
HPAF-II) were plated onto matrices, and their behaviors
were measured for average velocity (AV), net path dis-
tance (D), path trajectory (T), and directionality (D/T
r a t i o )( F i g u r e4 ) .T h ei n v a s i v eb e h a v i o r so fA s P C - 1( A V
= 5.1 ± 0.7, D = 9.5 ± 2.9, T = 54.8 ± 5.0) and HPAF-II
cells (AV = 5.5 ± 1.7, D = 16.6 ± 4.8, T = 58.1 ± 18.1)
were found to be less effective than the behaviors of
Capan-1 (AV = 11.3 ± 0.7, D = 32.2 ± 0.7, T = 120.8 ±
7.9) and Panc-1 cells (AV = 12.0 ± 1.4, D = 94.1 ± 13.1,
T = 128.2 ± 15.0) within the FAP
+ matrix. The greater
average velocity of Capan-1 and Panc-1 correlated with
their known enhanced ability to metastasize in vivo [41].
Although Capan-1 and Panc-1 cells presented similar
velocities, they showed significant differences in their
movement patterns as Panc-1 cells invaded using greater
directional motilities (D/T = 0.72 ± 0.05) compared to
the more random paths taken by the Capan-1 cells (D/T
= 0.28 ± 0.02, p < 0.001). However, no significant differ-
ences in velocity or directionality were observed using
these cells cultured within the FAP
- matrices (not
shown).
In order to question whether FAP
+ matrix effects pro-
moting cell motility of invasive pancreatic cancer cells
(i.e., Panc-1) are specific for pancreatic cancers, we
repeated this series of experiments using three well
characterized breast cell lines. Additional file 3, Fig. S3
shows that compared to immortalized normal MCF-10A
(AV = 7.59±1.3, D/T = 0.348±0.09) and tumorigenic
MCF-7 (AV = 4.88±0.65, D/T = 0.17±0.042), highly
invasive MDA-MB-231 cells moved faster (AV = 12.0
±1.0, p = 0.04, p < 0.001, respectively) and more direct
(D/T = 0.68±0.04, p = 0.001, p < 0.001, respectively) on
FAP
+ matrix. The results demonstrate that FAP
+ matrix
effects may be important in neoplasias other than just
pancreatic cancers.
Figure 3 FAP modulates the expression levels of stromal a-
SMA and assorted ECM molecules. Western analyses were used
to determine the levels of desmoplastic marker a-SMA and assorted
ECM proteins underlying the matrix differences mediated by FAP
expression. The normalized fold ratios of the selected proteins by
loading controls (b-actin or GAPDH) were assigned as one arbitrary
unit. Compared to FAP
- matrix proteins, a-SMA, fibronectin, and
collagen I were significantly up-regulated in FAP
+ 3D matrices (p =
0.009, p = 0.002, p = 0.001, respectively), while tenascin C was
significantly down-regulated (p = 0.001). Note that although
collagen I levels were rescued (p = 0.007) by inhibition of FAP
activity during matrix production (FAP+inhibitor), levels of
expression of fibronectin and a-SMA were only significantly
increased when compared to FAP
- (p = 0.04 in both cases) but not
to FAP
+ (p = 0.32 and p = 0.61, respectively). *denotes statistical
significance.
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+ 3D matrices represent a permissive
environment for pancreatic (and breast cancer) invasion,
and perhaps these matrices play an equally important
role along with the epithelial cell component. Given
their matrix-induced velocity and persistent directional-
ity, Panc-1 (and in some instances MDA-MB-231) cells
were selected for the further studies.
FAP
+ 3D matrices induce enhanced invasion behaviors
upon Panc-1
To test the contribution of FAP in the matrix-induced
permissive tumor behavior, Panc-1 cells were seeded
onto the three distinct matrices produced from the
FAP
- ,F A P
+, or FAP+inhibitor fibroblasts (Figure 5).
Compared to cells in FAP
- matrix (AV = 7.8 ± 0.8, D/T
= 0.36 ± 0.04), Panc-1 cells presented greater velocity
and directional motility within FAP
+ matrix (AV = 12.0
± 1.4 and D/T = 0.72 ± 0.06) (p = 0.05 and p < 0.001,
respectively). In addition, directionality was significantly
attenuated on FAP+inhibitor matrix (D/T = 0.52 ± 0.06,
p = 0.01), with a minor inhibition in the velocity (AV =
9.1 ± 1.6, p = 0.19). These results demonstrate that velo-
city and directionality of cells depend on the type of
ECM, which can differ if the matrix-producing fibro-
blasts express FAP or not. In addition, these results sug-
gest that while velocity is FAP dependent regardless of
its activity, directionality is strictly dependent on FAP
enzymatic activity.
Matrix-mediated invasive phenotypes are regulated by
b1-integrins
Integrins are the major receptors that link the ECM tumor
microenvironment with the migrating cancer cell. Given
the enhanced expression of ECM proteins and rearranged
fibronectin fiber orientation in FAP
+ matrix, the contribu-
tion of integrins responsible for the invasiveness of Panc-1
on matrix was investigated by time-lapse acquisition assays
performed in the presence of functional blocking agents,
including the b1-integrin antibody mAb13 and the a5b1-
integrin blocking peptide ATN-161 (Figure 6). Compared
to the control experiment using rabbit serum (AV = 13.55
± 2.25, D/T = 0.64 ± 0.07), inhibition of b1-integrins
Figure 4 Cell-dependent motility phenotypes were observed in FAP
+ matrix. To determine ECM effects on the invasive behaviors of cancer
cells, time-lapse acquisition assays were performed on FAP
+ matrices using pancreatic cancer cell lines. Representative tracks are shown where
each cell line presented distinct responses to the FAP
+ matrix as measured by average velocity (μm/hr) and directionality (D/T). Statistical
significances were marked using asterisks.
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Page 8 of 13Figure 6 Matrix-mediated Panc-1 invasive phenotypes are regulated by b1-integrin. To determine the engagement of integrins for the
invasiveness of Panc-1 in FAP
+matrix, time-lapse acquisition assays were performed in the presence of functional blocking b1-integrin antibody
mAb13 and blocking peptide ATN-161. (A) Panels are shown representative examples of migration tracks of individual cells invading through
assorted matrices. (B) Distinct responses of Panc-1 cells to the integrin inhibition were measured by average velocity and directionality.
Compared to the control experiment using rabbit serum, inhibition of b1-integrins significantly attenuated both velocity (67% inhibition, p <
0.001) and directionality (70% inhibition, p < 0.001) of Panc-1 cells in FAP
+ but not in FAP
-matrix (p = 0.07 and p = 0.06, respectively). In
addition, specific inhibition of a5b1-integrin decreased both velocity (43% inhibition, p = 0.002) and directionality (53% inhibition, p < 0.001) of
Panc-1 cells on FAP
+ matrix. Statistical significances were marked using asterisks.
Figure 5 FAP
+ ECMs promote a tumor permissive microenvironment. To test the effects of FAP on the behavior of cancer cells, Panc-1 cells
on assorted ECMs were monitored using time-lapse acquisition. Compared to their behavior within FAP
- matrix, Panc-1 cells presented increased
velocity and directionality within FAP
+ matrix (p = 0.05 and p < 0.001, respectively). When compared to behaviors induced by FAP
+ matrices,
Panc-1 cells on FAP+inhibitor matrix attenuated net path distances (D) and directionality (p = 0.07 and p = 0.01, respectively), but not velocity (p
= 0.19). Statistical significances were marked using asterisks.
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Page 9 of 13significantly attenuated both velocity (AV = 4.46 ± 0.49,
67% inhibition, p < 0.001) and directionality (D = 0.19 ±
0.03, 70% inhibition, p < 0.001) of Panc-1 cells on FAP
+
matrix. However, these significant inhibitions were not
observed on cells using FAP
- matrix (p = 0.07 and p =
0.06, respectively). This result suggests that b1-integrin is
an important regulator of tumor cell motility in FAP
+ but
not FAP
- matrices. Similar to results above, questioning
the matrix specific effect on only pancreas tumorigenesis,
here we decided to test FAP
+ matrix motility effects
imparted upon MDA-MB-231 cells in the presence or
absence of mAb-13. Results suggest that the observed FAP
+ matrix induced increase in MDA-MB-231 motility is
also dependent on b1-integrin activity (Additional file 4,
Fig. S4).
Given the enhanced expression and spatial orientation of
f i b r o n e c t i ni nF A P
+ matrix, the importance of the fibro-
nectin receptor a5b1-integrin was also tested. Inhibition of
a5b1-integrin using ATN-161 showed significant decrease
in the FAP
+ matrix-induced invasive behavior of Panc-1
cells (Figure 6). Compared with controls, inhibition of
a5b1-integrin decreased both velocity (AV = 7.73 ± 0.84,
43% inhibition, p = 0.002) and directionality (D = 0.34 ±
0.03, 53% inhibition, p < 0.001) of cells on FAP
+ matrix,
although not to the same extent as that of more general
integrin inhibitors. Given the incomplete abrogation of
invasive behavior of Panc-1 cells in the presence of ATN-
161, it is possible that additional b1-integrins could also
contribute to pancreatic cancer invasion facilitated by the
FAP
+ 3D matrices. In summary we concluded that, since
the enhanced motility of Panc-1 cells on FAP
+ 3D
matrices can be significantly reversed by blocking the
function of b1-integrins, a potential mechanism of matrix
mediated tumor invasion is an attractive possibility.
FAP
+-dependent enhanced invasion behavior of Panc-1 is
regulated by the b1-integrin/FAK signaling pathway
Integrin-mediated signaling pathways are often associated
with AKT and/or FAK effectors, resulting in proliferation,
survival, and invasion of tumor cells [42]. To determine
the downstream components of b1-integrins, Panc-1 cells
were cultured within assorted 3D matrices and the consti-
tutive activity levels of both AKT and FAK were analyzed
by the ratios of pS
473-AKT/total AKT and pY
397-FAK/
total FAK, respectively (Figure 7). As shown in Figure 7A,
constitutive FAK activity levels of Panc-1 cells cultured
within both FAP
+ and FAP+inhibitor matrices were signif-
icantly up-regulated ~1.5 fold compared to its activity in
FAP
- matrix (p = 0.007 and p = 0.03, respectively). When
activity levels were comparedf o rP a n c - 1c e l l sc u l t u r e d
within the assorted matrices in the presence or absence of
mAb13, a significant down-regulation of constitutive FAK
activity levels under b1-integrins inhibition was observed
in all three matrices (p = 0.02, p = 0.002, p = 0.02 for FAP
-
,F A P
+, FAP+inhibitor matrices, respectively). However,
constitutive levels of AKT activity in Panc-1 cells cultured
within the various matrices remained unchanged (all p >
0.18, Figure 7B). In addition, inhibition of a5b1-integrin
with ATN-161 did not show any changes in the activities
of FAK or AKT (all p > 0.2), suggesting that the specific
integrin contributions to the total AKT and FAK activity
levels are undetectable by this method, nevertheless,
ATN-161 effects were shown in the motility assay (Figure
6). In summary, up-regulation of FAK activity in Panc-1
cells on FAP
+ matrix and down-regulation of its activity
by function blocking b1-integrin suggest that the FAP
+-dependent enhanced invasion behavior of Panc-1 is
regulated by the b1-integrin/FAK signaling pathway, and
although a5b1-integrin seems to play a role, additional b1-
integrins may also participate in this regulatory process.
Discussion
In this work, we provide evidence that FAP is important
for remodeling a permissive stromal ECM that supports
pancreatic (and perhaps also breast) cancer invasion in
vitro. The experimental approach used to study the role
of FAP in tumor invasion utilized an in vivo-like 3D
matrix system that has been shown to effectively
Figure 7 FAP
+ matrix-induced Panc-1 invasion is dependent of
FAK. Panc-1 cells were cultured within the assorted matrices for 2
days in the presence of mAb13, ATN-161, or rabbit sera. The specific
activity of the kinases was calculated as the ratio of the scanned
optical densities of the phosphorylated forms divided by total
expression levels (P/T). The fold of P/T ratios being assessed
obtained from FAP
- matrices (square box) was assigned as one
arbitrary unit. (A) Constitutive FAK activity levels of Panc-1 cells
induced by FAP
+ matrix were up-regulated by ~1.5 fold (p = 0.007).
Inhibition of b1-integrin activity significantly blocked the FAK
activity levels of Panc-1 cells cultured within both FAP
- and FAP
+
matrices (p = 0.02 and p = 0.002, respectively). However, inhibition
of a5b1-integrin showed no significant changes in FAK activity levels
(all p > 0.3). (B) AKT activity in Panc-1 cells on matrices remained
unchanged in the presence or absence of inhibitory agents.
Statistical significances were marked using asterisks.
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Page 10 of 13recapitulate stromal ECMs from various murine and
human tissues [21,28,43]. Fibroblasts-derived 3D matrix
system can avoid the flat surface of a tissue culture dish
which impose an artificially rigid environment onto the
cell [44]. On recent studies analyzing the direct effects
of tumor stromal ECMs on cancer cell behavior, we
demonstrated (among other things) that different breast
cancer cell lines present distinct cell motility phenotypes
when cultured within tumor-associated ECMs [37].
Here we also performed assays using the same breast
cancer lines on our FAP
+ matrices and found that FAP
+
matrices effectively recapitulate many aspects of tumor-
associated ECMs (data shown in supplemental material).
Thus FAP
+ matrices were utilized as a stromal land-
scape to study matrix-induced pancreatic (and in some
instances breast) cancer cell behaviors.
In this study, we observed that FAP
+ fibroblast-derived
matrices presented higher organization levels of fibers
when compared to FAP
- matrices. Importantly, we
showed that FAP
+ matrices contain parallel fiber organi-
zation features that are reminiscent of tumor-associated
ECMs of pancreatic desmoplastic tissues associated with
pancreatic adenocarcinoma looking at human normal
and tumor ECMs both in vivo and in vitro. The observed
enhanced directionality and velocity of cancer cells
invading through FAP
+ 3D matrices was effectively
reversed in matrices produced from FAP
+ fibroblasts in
the presence of FAP enzymatic inhibitor. By determining
alterations in collagen at the vicinity of tumors in vivo,i t
has been suggested that a strong relationship exists
between both collagen density and matrix architectural
organization and observed increased breast tumorigenesis
[22]. Likewise, tumor-associated collagen features similar
to the above-mentioned were observed by depleting FAP
in vivo [45]. Interestingly, our human pancreatic adeno-
carcinoma-associated fibroblast ECMs, as well as our
FAP
+ 3D matrices in vitro, also presented the parallel
organized patterns highlighted by the two studies above.
These facts reinforce the notion that our in vitro models
may be regarded as being highly relevant.
Our FAP+inhibitor matrices resembled FAP
- matrices
with lower ECM levels of organization and supported
relatively impeded tumor cell behaviors. We also report
that inhibition of b1-integrins abrogates the FAP
+ ECM
facilitated invasive capabilities of pancreatic and breast
tumor cells, suggesting that a cell-matrix b1-integrin
engagement is important for this FAP
+ matrix-dependent
process. We elucidated a potential molecular mechanism
underlying the enhanced pancreatic cancer cell motility
mediated by FAP
+ matrix. We found that FAP remodels
the extracellular matrices through alterations of ECM
proteins levels, as well as through increased fibronectin
fiber patterned orientation. FAP expression regulates
tenascin C, collagen I, fibronectin and a-SMA
expressions, all known to play important roles in pan-
creatic tumorigenesis [7,46]. FAP activity seems to be
important for the positive collagen I and the negative
tenascin C regulation, yet absence of FAP activity seems
to significantly block collagen I while enhancing fibro-
nectin and a-SMA levels of expression. Our results sug-
gest that FAP enzymatic activity plays a role not only in
regulating fiber orientation but also in regulating expres-
sion levels of collagen I. Moreover, we were able to dis-
tinguish among FAP expression and/or activity
dependent functions in regulating stromal markers.
When measuring the levels of collagen I expression, we
observed that, while FAP activity is important to both
fibronectin and collagen architectural fiber organization,
this activity is mostly important for assessing collagen I
as opposed to fibronectin (or a-SMA) levels of expres-
sion. In summary, we observed that both FAP expression
and/or activity dependent functions can regulate ECMs
compositions.
Interestingly, we learned that the velocity of the
migrating cancer cells is dependent on FAP expression
regardless of its activity, whereas the latter is crucial for
directionality. The observed change in architecture and
the levels of components of the ECM leads to enhanced
ECM permissiveness, which facilitates pancreatic cancer
invasiveness via b1-integrin engagement. Interestingly,
our results using MDA-MB-231 cells were comparable
to the ones observed with Panc-1, and thus we con-
cluded that fibroblastic FAP-dependent matrix altera-
tions and the importance of b1- i n t e g r i ni nt h e
regulation of cancer cell motility are effects that are not
necessarily restricted to pancreatic cancers and that
additional cancers such as breast, where stromal FAP
expression levels have been shown to be increased [47],
show similar behaviors. Furthermore, FAP
+ matrix-
induced regulatory molecules in cancer cells revealed
that it is associated with an increased activation of FAK
that is independent of AKT activity. Because b1-integ-
rins are major receptors responsible for ECM assembly,
these results suggest that FAP remodels ECM fibers to
provide directional paths for pancreatic (and other can-
cer, i.e., breast) cells to engage b1-integrin/FAK for inva-
sion. As a response to altered signals from the tumor
stroma, cancer cell behavior seems to be influenced
through patterning of the underlying matrix, resulting in
track-dependent cellular migration. Conversely, the inhi-
bition of a5b1-integrin function only partially affected
FAP
+ matrix-induced Panc-1 invasion. This specific
integrin inhibition did not significantly alter the consti-
tutive FAK activation seen in Panc-1 cells cultured into
FAP
+ matrices, suggesting that additional members of
the b1-integrin family are also responsible for the
matrix-induced effects. Importantly, the changes in the
ECM produced by FAP
+ fibroblasts effectively
Lee et al. BMC Cancer 2011, 11:245
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Page 11 of 13recapitulate many aspects of stromal ECMs, including
increased tumorigenic behaviors [37], enhance ability to
metastasize in vivo [41], promote epithelial cancer cells
to move along insoluble tumor-associated ECM fibers
leading them towards the intravasation sites during
metastasis [48], and recapitulate pancreatic stromal
characteristics, such as increased collagen I expression
and up-regulation of desmoplastic marker a-SMA [49].
Conclusions
Our data suggests that cancer cell invasiveness can be
affected by alterations in the tumor microenvironment.
We provide evidence that FAP is important for remodel-
ing a permissive stromal ECM to produce directional
paths for pancreatic (and breast) cells that engage b1-
integrin/FAK for invasion. Therefore, our observations
imply that a better understanding of the changes in stro-
mal fibroblasts and their influence on epithelial tumor cell
behavior can lead to novel strategies for the prevention
and treatment of cancer. The identification of fibroblastic
3D-dependent signaling pathways may be important to
block the transition to a permissive microenvironment
and even reverse stromal fibroblast-dependent neoplasia
[44]. This study provides the pre-clinical rationale that
inhibition of FAP proteolytic activity and selected b1-
integrin family members in combination may abrogate the
invasive capabilities of pancreatic tumors by interfering
with the architectural organization of tumor-associated
ECMs and disrupting the tumor-stromal interactions.
Additional material
Additional file 1: Figure S1; FAP is selectively overexpressed in
tumor stromal fibroblasts. (A) In human pancreatic cancer patient
samples, FAP is highly expressed in stromal fibroblasts (red arrows) but
not in epithelial tumor components (black arrows) [18]. A parallel
patterned ECM organization (*) is observed within the desmoplastic
stromal reaction. (B) In a xenograft mouse model, human pancreatic
cancer cell lines (HPAF-II, Capan-1, AsPC-1, and Panc-1) also induced
murine FAP expression in the tumor stroma but not in tumor cells.
Hematoxylin (blue) was used for counterstaining.
Additional file 2: Figure S2; FAP
+ fibroblasts affect the architectural
patterns of collagen I fiber organization. Un-extracted matrices were
subjected to indirect immunofluorescence using a collagen I antibody
(green) and their nuclei stained using DAPI (blue). Note FAP
+ fibroblasts
produced ECM fibers with enhanced parallel patterns compared to both
FAP
- and FAP+inhibitor matrices.
Additional file 3: Figure S3; A cell type dependent motility is
observed in FAP
+ matrices using immortalized and neoplastic
breast cell lines. To test the general effect of FAP
+matrices in
promoting motility of invasive cancer cells, three human breast cell lines
(immortalized normal MCF-10, tumorigenic MCF-7, and invasive MDA-
MB-23) were assessed. Note that compared to MCF-10A and MCF-7,
invasive MDA-MB-231 cells presented a faster (p = 0.04, p < 0.001,
respectively) and more direct (p = 0.001, p < 0.001, respectively) motility
within these permissive 3D matrices. Statistical significances were marked
using asterisks.
Additional file 4: Figure S4; Matrix-mediated MDA-MB-231 invasive
phenotypes are regulated by b1-integrin. To confirm the engagement
of integrins for the invasive characteristics of MDA-MB-231 on FAP
+
matrix, time-lapse motility assays were performed in the presence of
anti-integrin b1 antibody mAb13, the aVb3 specific integrin antibody
LM609, and rabbit sera as a control. (A) Panels are shown representative
examples of migration tracks of individual cells invading though assorted
matrices. (B) Distinct responses of MDA-MB-231 cells to the integrin
inhibition were measured by average velocity and directionality.
Compared to the control, inhibition of b1-integrins significantly
attenuated both velocity (p < 0.001) and directionality (p < 0.001) of cells
in FAP
+ but not in FAP
- matrix. In addition, specific inhibition of aVb3-
integrin decreased velocity (p < 0.001) but not directionality on FAP
+
matrix. Statistical significances were marked using asterisks.
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